Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas

Clinical and Translational Oncology

Volumn 9, Issue 11, 2007, Pages 731-736

  Pina Cabral, L ^a   Santos, L ^b   Mesquita, B ^a,b   Amaro, T ^b   Magalhaes S ^b   Criado, B ^a  

^a CESPU   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

mRNA; Survivin; Tumour marker; Urinary cytology

Indexed keywords

MESSENGER RNA; SURVIVIN; TUMOR MARKER; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; MALE; PROGNOSIS; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERFICIAL UROTHELIAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINE CYTOLOGY; BLADDER TUMOR; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; URINE; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 39749128447     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0130-4     Document Type: Article

References (20)

1. Baithun S, Daruwala P, Oliver RT (1998) Squamous changes in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer. Cancer Surv 31: 17-27
2. Yudong W, Wang G, Wei J, Wen X (2005) Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer. Indian J Med Sci 59:235-242
3. Sharp JD, Hausladen DA, Maher MG et al (2002) Bladder cancer detection with urinary survivin, an inhibitor of apoptosis. Frontiers Biosci 7:e36-41
4. Wiener HG, Vooijs GP, Hof-Grootenboer BV (1993) Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37:163-169
5. Ramakumar S, Bhuiyan J, Besse JA (1999) Comparison of screening methods in the detection of bladder cancer. J Urol 161:388-394
6. Weikert S, Christoph F, Schrader M et al (2005) Quantitative analysis of survivin mRNA expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116:100-104
7. Ku J, Kwak C, Lee H et al (2004) Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171:631-635
8. Schultz IJ, Kiemeney LA, Witjes JA et al (2003) Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23:3327-3331
9. Shariat SF, Casella R, Khoddami SM et al (2004) Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171:626-630
10. Smith SD, Wheeler MA, Plescia J et al (2001) Urine detection of survivin and diagnosis of bladder cancer. JAMA 285:324-328
11. Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452-453
12. Wang H, Xi X, Kong X, Ge GHG (2004) The expression and significance of survivin mRNA in urinary bladder carcinomas. J Cancer Res Clin Oncol 130:487-490
13. Schultz IJ, Kiemeney LA, Karthaus HFM et al (2004) Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 50:1425-1428
14. Hausladen DA, Wheeler MA, Altieri DC et al (2003) Effect of intravesical treatment of transitional cell carcinoma with bacillus calmetteguerin and mitomycin C on urinary survivin levels and outcome. J Urol 170:230-234
15. Mostofi FK, Sorbin LH, Torloni H (1973) Histological typing of urinary bladder tumours. International histological classification of tumours, 19. Geneva: World Health Organization
16. American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th Edn. New York: Lippincott-Raven
17. Gazzaniga P, Gradilone A, Giuliani L et al (2003) Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14:85-90
18. Hoffman WH, Biade S, Zilfou JT et al (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247-3257
19. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M et al (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784-788
20. Santos L, Amaro T, Costa C et al (2003) KI-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 105:267-272